Novel AC133 isoforms distinguish circulating from incorporated AC133 cells during tumor growth.

被引：0
|
作者：
Igreja, C
Courinha, M
Silva, MG
Dias, S
机构：
[1] Inst Portugues Oncol Francisco Gentil, CIPM, Angiogenesis Lab, Lisbon, Portugal
[2] Inst Portugues Oncol Francisco Gentil, Dept Hematol Oncol, Lisbon, Portugal
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2875
引用
收藏
页码：786A / 786A
页数：1
相关论文
共 50 条
  • [21] AC133(CD133)与急性白血病
    周余
    王亚非
    国外医学输血及血液学分册., 2003, (05) : 447 - 450
  • [22] Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells
    Horn, PA
    Tesch, H
    Staib, P
    Kube, D
    Diehl, V
    Voliotis, D
    Schoch, C
    BLOOD, 1999, 93 (04) : 1435 - 1437
  • [23] CD133 (AC133) antigen expression on leukemic cells of adults with acute leukemia
    Krol, MA
    Czuba, E
    Dwilewicz-Trojaczek, J
    Wiktor-Jedrzejczak, W
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 341 - 344
  • [24] Analysis of human haemopoietic cells isolated with the novel AC133 monoclonal antibody.
    de Wynter, EA
    Hart, C
    Coutinho, LH
    Gagen, D
    Chang, J
    Buck, D
    Testa, NG
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 739 - 739
  • [25] AC133 antigen expression on acute leukemic blasts.
    Min, YH
    Lee, ST
    Jang, JH
    Lee, MY
    Hahn, JS
    Ko, YW
    BLOOD, 1999, 94 (10) : 209B - 209B
  • [26] Expression of the AC133 antigen in leukemic and normal progenitors.
    Snell, V
    Jackson, E
    Buck, D
    Andreeff, M
    BLOOD, 1998, 92 (10) : 119A - 119A
  • [27] Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin
    S Bhatia
    S Reister
    C Mahotka
    R Meisel
    A Borkhardt
    E Grinstein
    Leukemia, 2015, 29 : 2208 - 2220
  • [28] Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin
    Bhatia, S.
    Reister, S.
    Mahotka, C.
    Meisel, R.
    Borkhardt, A.
    Grinstein, E.
    LEUKEMIA, 2015, 29 (11) : 2208 - 2220
  • [29] Clinical importance of AC133 and CD34 expression on AML cells.
    Horn, PA
    Tesch, H
    Staib, P
    Schoch, C
    Diehl, V
    Voliotis, D
    BLOOD, 1999, 94 (10) : 205B - 205B
  • [30] Ac133 defines a highly proliferative subpopulation of primitive and committed hematopoietic cells (HC).
    Huang, S
    Yin, AH
    Buck, D
    Young, D
    Lane, TA
    Ho, AD
    Law, P
    BLOOD, 1998, 92 (10) : 54A - 54A
12345